Market Overview:
The global multiple sclerosis treatment market is expected to grow at a CAGR of 7.5% during the forecast period 2018-2030. The market is segmented on the basis of type, application and region. On the basis of type, the market is segmented into immunomodulatory, immunosuppressive and interferons. Immunomodulatory drugs are further sub-segmented into natalizumab, fingolimod, teriflunomide and dimethyl fumarate (DMF). Immunosuppressive drugs are further sub-segmented into azathioprine sulfate (AZA), mycophenolate mofetil (MMF), cyclophosphamide (CYC) and methotrexate sodium (MTX). Interferons are further sub-segmented into pegylated interferon alfa 2a or 2b(PEG IFN α2a/β), recombinant interferon beta 1a(IFN β1a) and glatiramer acetate 20 mg/ml injection(GA 20 mg/ml). On the basis of application, the market is segmented into relapsing remitting MS, primary progressive MS and secondary progressive MS. In terms of sales channel, hospital pharmacy accounted for majority share in 2016 followed by retail pharmacy & online stores respectively.
Product Definition:
MS treatment is the use of medication or therapy to relieve symptoms and improve the quality of life for people with multiple sclerosis. Treatment may include drugs to reduce inflammation, drugs to improve nerve function, physical therapy, and counseling.
Immunomodulatory:
Immunomodulatory drugs are those that alter the immune system in a positive way. They do this by either increasing or decreasing the activity of certain proteins and enzymes involved in modulating the immune response. Immunomodulatory drugs can be used to treat a wide range of diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, cancer ( lymphoma/leukemia ), multiple sclerosis and others.
Immunosuppressive:
Immunosuppressive drugs are used to reduce the immune response to the brain, thereby reducing inflammation and improving symptoms of multiple sclerosis. The most common types of immunosuppressive drugs used for multiple sclerosis treatment include Copaxone, Avonex, Rebif, and Sativex.
Application Insights:
Based on application, the global market is segmented into hospital pharmacy, retail pharmacy, online stores and others. The hospital pharmacies dominated the overall industry in terms of revenue in 2016 owing to its ability to provide high-quality medicines at a lower cost as compared to other sources such as medical clinics or private practices.
The availability of advanced healthcare facilities along with highly skilled personnel and modern technology used for treatment purposes also contributes towards higher sales volume. In addition, these pharmacies offer services such as refills on a same day basis if the prescription is available from a doctor; otherwise it will be delivered next day free of charge (if ordered before Midnight). This service is provided by few hospitals only thus boosting product demand globally.
Regional Analysis:
North America dominated the global market in 2018. The presence of key players, favorable reimbursement policies, and availability of effective treatment for multiple sclerosis are some factors responsible for its large share. In addition, increasing awareness about multiple sclerosis among people is expected to fuel the growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in international travel has increased awareness about multiple sclerosis among people which will also drive demand during the forecast period from 2019 to 2030 (estimated).
In addition, a rise in cases of other autoimmune diseases due to change in lifestyle habits such as smoking or alcohol consumption may boost demand during this time frame (estimated). Moreover, growing medical tourism industry due to affordable treatments offered by various companies will also contribute towards regional growth (estimated).
Growth Factors:
- Increasing incidence of multiple sclerosis
- Growing awareness about the disease and its treatment options
- Rising demand for better and more effective therapies for multiple sclerosis
- Technological advancements in the field of MS treatment
- Availability of government funding for research on MS
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiple Sclerosis Treatment Market Research Report
By Type
Immunomodulatory, Immunosuppressive, Interferons, Others
By Application
Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027, Hospital Pharmacy, Retail Pharmacy, Online Stores
By Companies
Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis, CinnaGen, Mylan, Bristol-Myers Squibb, Janssen Pharmaceuticals, Acorda Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Multiple Sclerosis Treatment Market Report Segments:
The global Multiple Sclerosis Treatment market is segmented on the basis of:
Types
Immunomodulatory, Immunosuppressive, Interferons, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027, Hospital Pharmacy, Retail Pharmacy, Online Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck & Co
- Teva Pharmaceutical
- Sanofi
- Bayer
- Biogen
- Roche
- Novartis
- CinnaGen
- Mylan
- Bristol-Myers Squibb
- Janssen Pharmaceuticals
- Acorda Therapeutics
Highlights of The Multiple Sclerosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunomodulatory
- Immunosuppressive
- Interferons
- Others
- By Application:
- Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
- Hospital Pharmacy
- Retail Pharmacy
- Online Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiple Sclerosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Multiple sclerosis treatment includes medications and/or treatments to help manage the symptoms of multiple sclerosis. Medications may include corticosteroids, immunosuppressants, and disease-modifying antirheumatic drugs (DMARDs). Treatments may include physical therapy, speech therapy, occupational therapy, and psychological counseling.
Some of the major players in the multiple sclerosis treatment market are Pfizer, Merck & Co, Teva Pharmaceutical, Sanofi, Bayer, Biogen, Roche, Novartis, CinnaGen, Mylan, Bristol-Myers Squibb, Janssen Pharmaceuticals, Acorda Therapeutics.
The multiple sclerosis treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Multiple Sclerosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Multiple Sclerosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Multiple Sclerosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Multiple Sclerosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Multiple Sclerosis Treatment Market Size & Forecast, 2020-2028
4.5.1 Multiple Sclerosis Treatment Market Size and Y-o-Y Growth
4.5.2 Multiple Sclerosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Immunomodulatory
5.2.2 Immunosuppressive
5.2.3 Interferons
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
6.2.2 Hospital Pharmacy
6.2.3 Retail Pharmacy
6.2.4 Online Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Multiple Sclerosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Multiple Sclerosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Immunomodulatory
9.6.2 Immunosuppressive
9.6.3 Interferons
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
9.10.2 Hospital Pharmacy
9.10.3 Retail Pharmacy
9.10.4 Online Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Immunomodulatory
10.6.2 Immunosuppressive
10.6.3 Interferons
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
10.10.2 Hospital Pharmacy
10.10.3 Retail Pharmacy
10.10.4 Online Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Immunomodulatory
11.6.2 Immunosuppressive
11.6.3 Interferons
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
11.10.2 Hospital Pharmacy
11.10.3 Retail Pharmacy
11.10.4 Online Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Immunomodulatory
12.6.2 Immunosuppressive
12.6.3 Interferons
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
12.10.2 Hospital Pharmacy
12.10.3 Retail Pharmacy
12.10.4 Online Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Immunomodulatory
13.6.2 Immunosuppressive
13.6.3 Interferons
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Global Multiple Sclerosis Treatment Market Share by Sales Channel: 2016 VS 2021 VS 2027
13.10.2 Hospital Pharmacy
13.10.3 Retail Pharmacy
13.10.4 Online Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Multiple Sclerosis Treatment Market: Competitive Dashboard
14.2 Global Multiple Sclerosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck & Co
14.3.3 Teva Pharmaceutical
14.3.4 Sanofi
14.3.5 Bayer
14.3.6 Biogen
14.3.7 Roche
14.3.8 Novartis
14.3.9 CinnaGen
14.3.10 Mylan
14.3.11 Bristol-Myers Squibb
14.3.12 Janssen Pharmaceuticals
14.3.13 Acorda Therapeutics
